跳至主要内容
临床试验/NCT04009447
NCT04009447已完成不适用

Sleep Quality and Mechanisms of Cardiovascular Risks in Adults With Hypertension

Duke University1 个研究点 分布在 1 个国家目标入组 149 人开始时间: 2020年2月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
149
试验地点
1
主要终点
Change in Blood Pressure During the Nighttime Sleep Period

研究概览

简要总结

The objective of this study is to elucidate the potential mechanisms responsible for the increased risk of cardiovascular disease among patients with hypertension and comorbid insomnia.

详细描述

The investigators propose to utilize a behavioral intervention to manipulate sleep quality in 150 adults with hypertension and comorbid insomnia, who will receive a 6-week Cognitive Behavioral therapy for Insomnia (CBT-I) intervention, which has been shown to markedly improve sleep quality and promote consolidated sleep in approximately 60% of those treated. A lowering of nighttime blood pressure is one of several proposed mechanisms to be examined.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
30 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Systolic BP ≥ 130 mm Hg based upon two standardized BP screening assessments
  • A current diagnosis of insomnia disorder as defined in the International Classification of Sleep Disorders (ICSD-3); or undiagnosed, but suspected, insomnia disorder that is confirmed at their screening lab visit

排除标准

  • Uncontrolled hypertension (screening office BP > 160/100 mm Hg)
  • Antihypertensive medication use
  • Cardiovascular medications
  • Previously diagnosed moderate or severe obstructive sleep apnea
  • Severe obesity defined by BMI>40 kg/m2
  • Pacemakers
  • Atrial fibrillation
  • Acute coronary syndrome or coronary revascularization procedure within 6 months of enrollment
  • Congestive heart failure
  • Identifiable cause of hypertension (e.g., primary hyperaldosteronism, renal artery stenosis, untreated hyper- or hypothyroidism, chronic kidney disease, Cushing's disease, pheochromocytoma, coarctation of the aorta)
  • Severe uncorrected valvular heart disease
  • Current pregnancy
  • Active diagnosis of psychosis, bipolar disorder
  • Severely impaired hearing or speech
  • Participation in another interventional study to address insomnia
  • Rotating shift workers
  • Prominent suicidal or homicidal ideation (as assessed through a clinical interview)
  • Psychiatric Hospitalization within the past 12 months
  • Alcohol or drug abuse within 12 months
  • Exposure-based PTSD treatment
  • Unstable comorbid sleep disorder requiring assessment and/or treatment outside of the study protocol
  • Medical or psychiatric conditions judged to be the primary cause of insomnia
  • Inability to comply with the assessment procedures or inability to provide informed consent.

研究组 & 干预措施

Cognitive Behavioral Therapy for Insomnia

Other

Cognitive Behavioral Therapy for Insomnia (CBT-I) 6 sessions of Cognitive Behavioral Training for Insomnia (1 hour each).

干预措施: Cognitive Behavioral Therapy for Insomnia (CBT-I) (Behavioral)

结局指标

主要结局

Change in Blood Pressure During the Nighttime Sleep Period

时间窗: Baseline, 6 months post-intervention

Average nighttime blood pressure measured before CBT-I (Cognitive Behavioral Therapy for Insomnia) (baseline) and after CBT-I (6 months post-intervention).

Change in Sleep During the Nighttime Sleep Period as Measured by Sleep Diary

时间窗: Baseline, 6 months post-intervention

Sleep efficiency (percent-time asleep during the sleep period) measured before CBT-I (Cognitive Behavioral Therapy for Insomnia) (baseline) and after CBT-I (6 months post-intervention).

Change in Sleep During the Nighttime Sleep Period as Measured by Actigraphy

时间窗: Baseline, 6 months post-intervention

Sleep efficiency (percent-time asleep during the sleep period) measured by actigraphy before CBT-I (Cognitive Behavioral Therapy for Insomnia) (baseline) and after CBT-I (6 months post-intervention).

Changes in Insomnia Severity as Measured by the Insomnia Severity Index (ISI)

时间窗: Baseline, 6 months post-intervention

The ISI is a seven-item questionnaire where respondents rate each element using Likert-type scales. Responses can range from 0 to 4 and are summed for a total score range of 0 to 28, where higher scores indicate more acute symptoms of insomnia.

次要结局

  • Change in Awake Blood Pressure(Baseline, 6 months post-intervention)
  • Change in Nighttime Blood Pressure Dip Percentage(Baseline, 6 months post-intervention)
  • Change in Vascular Endothelial Function(Baseline, 6 months post-intervention)
  • Change in Arterial Stiffness(Baseline, 6 months post-intervention)
  • Change in Lipid Profile - HDL (High-Density Lipoprotein), LDL (Low-Density Lipoprotein), and Triglycerides(Baseline, 6 months post-intervention)
  • Change in Nighttime Sympathetic Nervous System Activity(Pre-CBT-I Baseline (6 weeks) to post-CBT-I (12 weeks))
  • Change in Sleep Fragmentation During the Nighttime Sleep Period(Baseline, 6 weeks post-intervention)
  • Change in Subjective Sleep Quality(Pre-CBT-I baseline (6 week) to post-CBT-I (12 weeks))
  • Change in Clinic Blood Pressure(Baseline to 6 months post-intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验